A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/55 (2006.01) A61K 31/00 (2006.01) A61K 31/138 (2006.01) A61K 31/15 (2006.01) A61K 31/335 (2006.01) A61K 31/36 (2006.01) A61K 31/395 (2006.01) A61K 31/40 (2006.01) A61K 31/4015 (2006.01) A61K 31/4025 (2006.01) A61K 31/42 (2006.01) A61K 31/44 (2006.01) A61K 31/4406 (2006.01) A61K 31/443 (2006.01) A61K 31/4433 (2006.01) A61K 31/4439 (2006.01) A61K 31/445 (2006.01) A61K 31/4453 (2006.01) A61K 31/4525 (2006.01) A61K 31/454 (2006.01) A61K 31/495 (2006.01) A61K 31/498 (2006.01) A61K 31/4985 (2006.01) A61K
Patent
CA 2250856
Affective disorders in humans are treated by enhancing glutamatergic transmission. This is achieved in various ways, one of which is by the administration of a class of therapeutic agents having a phenyl ketone- containing molecular structure and similar to the structure of aniracetam. This discovery is based on tests using REM sleep reduction in an animal model as an indicator.
On traite les désordres affectifs chez l'homme en renforçant la transmission glutamatergique. Pour ce faire plusieurs méthodes sont possibles, notamment l'administration d'une classe d'agents thérapeutiques présentant une structure moléculaire contenant du phénylcétone, semblable à la structure de l'aniracétam. Cette découverte est fondée sur des essais portant sur la réduction du sommeil paradoxal chez un modèle animal servant d'indicateur.
Ambros-Ingerson Jose
Lynch Gary
Smart & Biggar
The Regents Of The University Of California
LandOfFree
Treatment of mood/affective disorders by glutamatergic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of mood/affective disorders by glutamatergic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of mood/affective disorders by glutamatergic... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1457453